[PDF] Top 20 New Therapeutic Approaches for the Treatment of Huntington’s Disease
Has 10000 "New Therapeutic Approaches for the Treatment of Huntington’s Disease" found on our website. Below are the top 20 most common "New Therapeutic Approaches for the Treatment of Huntington’s Disease".
New Therapeutic Approaches for the Treatment of Huntington’s Disease
... symptomatic treatment of chorea in HD pa- tients, but its role in slowing the disease process is unclear ...progressive disease, as- sociated with multiple degeneration, they allow us study different ... See full document
5
The old and new therapeutic approaches to the treatment of giardiasis: Where are we?
... In conclusion, this review raises some problems regarding the evidence for using old and new antigiardial drugs, in relation to the quality of previous and future studies. Yet, one must point out that the drugs in ... See full document
15
New therapeutic approaches in alcohol dependence: reduction of consumption as a step in the therapeutic goal
... During treatment there is an important and active dual role of both the doctor and patient who should share common goals resulting from accurate analysis of the motivation and personological character- istics of ... See full document
8
Varenicline improves motor and cognitive symptoms in early Huntington’s disease
... Huntington’s disease (HD) who were current ...Huntington’s Disease Rating Scale part I and III (motor and behavioral subscales) at baseline and after 4 weeks of ... See full document
6
Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
... Huntington’s disease (HD) is caused by a genetic mutation that results in polyglutamine expansion in the N-terminal regions of ...effective treatment for different neurodegenerative diseases that are also ... See full document
10
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease
... the treatment of chorea in Huntington’s disease (HD) and is the first deuterated medication that has been US Food and Drug Adminis- tration (FDA)-approved for therapeutic ...effective ... See full document
7
Treatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington’s disease
... Huntington’s disease (HD) is a neurodegenerative disease characterized by motor dysfunction and early ...provide new insights or new therapy for ...B401 treatment was alleviated as ... See full document
14
Treatment of Huntington's disease Using Medieval Iranian Practice
... Huntington's disease (HD) is thought to be due to genetically-programmed degeneration of neurons in certain areas of the ...the disease started tormenting human beings, and to date, conventional medications ... See full document
5
Management of Huntington’s disease: role of tetrabenazine
... Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder characterized by progressive involuntary movements, neuropsychiatric disturbances, and cognitive ...the treatment of HD patients ... See full document
7
Epidemiology and health care utilization of patients suffering from Huntington’s disease in Germany: real world evidence based on German claims data
... Methods: The source of data was a sample of the Institute for Applied Health Research Berlin (InGef) Research Database, comprising data of approximately four million insured persons from approximately 70 German statutory ... See full document
8
Update and new approaches in the treatment of Castleman disease
... delineated CD as a heterogeneous cluster of disorders, with distinct unicentric CD (UCD) and multicentric CD (MCD) subtypes, and identified the fundamental roles of human herpesvirus-8 (HHV-8) and interleukin-6 (IL-6) in ... See full document
14
Modern Approaches and Strategies for Prevention and Therapeutic Influence of Alzheimer's Disease
... Alzheimer's disease is a chronic progressive polypathogenic neurodegenerative disease in which the combination of various mechanisms and risk factors and the appearance of amyloid plaques and ... See full document
16
Novel targets for Huntington’s disease: future prospects
... mechanistic, disease-modifying treatments in HD, looking at a number of possible ...different treatment targets. Nevertheless, HD remains a rare disease with a limited number of patients, which has ... See full document
12
Clinical diagnosis and management in early Huntington's disease: a review
... The treatment of symptoms in JHD should not be restricted to pharmaceutical approaches but has to involve a multidisciplinary team respecting all needs of the affected individual and his/her surrounding to ... See full document
14
Oligonucleotide therapeutic approaches for Huntington disease
... promising approaches to disease modification that have been enabled by a unique feature of their mechanisms of action — direct intervention at the mRNA level to reduce production of the causative pathogenic ... See full document
9
ALZHEIMER'S DISEASE THERAPEUTIC APPROACHES
... Major unsolved problems in biochemistry are protein folding. It has been recognized as the most critical obscure in the current century, because of the complex protein structure, which makes it difficult in predicting ... See full document
8
PKR involvement in Alzheimer’s disease
... of new PKR inhibitors seems to be an appropri- ate goal for a new therapeutic approach, especially if the sum of the early initial brain cellular events can contribute to the activation of PKR and ... See full document
10
New approaches in the treatment of short term and middle of the night insomnia: emerging evidence for a role for sublingual zolpidem tablets
... This study included evaluation of the objective and subjective effects of zolpidem treatment on morning functioning. Participants completed the DSST and a visual analog scale (VAS) asking for self-report of level ... See full document
7
New therapeutic strategies for the treatment of male lower urinary tract symptoms
... combination treatment to control voiding ...combination therapeutic strategies with α 1 -blockers and antimuscarinics or β 3 -agonists have been introduced to manage symptoms ... See full document
9
Huntington's disease: a clinical review
... The characteristic motor changes are involuntary, unwanted movements. Initially, the movements often occur in the distal extremities such as fingers and toes, but also in small facial muscles. For bystanders these muscle ... See full document
8
Related subjects